|
Dr. Frank Malinoski is MedImmune’s senior vice president, medical and scientific affairs. In this role, he oversees medical and scientific activities relating to marketed products, including clinical trials and medical information. Dr. Malinoski joined MedImmune as vice president, infectious disease, medical affairs in December 2005, with responsibility for MedImmune’s infectious disease and vaccines group within medical affairs.
Prior to joining MedImmune, Dr. Malinoski was president of TD Consultancy, a consulting practice advising industry and government clients on vaccine development issues. Previously, he worked at Oxxon Therapeutics, Inc. as chief medical officer and executive vice president of development, and at Wyeth Pharmaceuticals, where he held positions of increasing responsibility including: vice president, global business development; vice president, medical affairs; and assistant vice president, clinical affairs.
Dr. Malinoski earned his Ph.D. in microbiology from Rutgers University and his M.D. from Albany Medical College. He holds a bachelor of arts degree from Colby College in Waterville, Maine. | 